President and CEO: Troy Wilson.
Financial information: Company has raised $41 million from investors.
No. of local employees: 36.
Investors: Sofinnova Ventures, CMEA Capital, Novartis Venture Funds, Abingworth, U.S. Venture Partners, FinTech Global Capital and Biogen Idec.
Headquarters: La Jolla.
Year founded: 2007.
Company description: A clinical-stage pharmaceutical biotech company discovering and developing small molecule drugs that treat cancer and other diseases.
Key factors for success: The company is focused on phosphoinositide 3-kinase inhibitors, or PI3K inhibitors, which are a hot target among major pharmaceutical companies.
One of the world’s largest pharmaceutical players, Takeda Pharmaceutical Co...